Operating Lease, Right-of-Use Asset of Guardant Health, Inc. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Guardant Health, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • Guardant Health, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $158,849,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Guardant Health, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $158,849,000 +$16,584,000 +12% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $163,550,000 +$18,586,000 +13% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $169,768,000 +$23,657,000 +16% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $140,500,000 -$11,381,000 -7.5% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $142,265,000 -$15,351,000 -9.7% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $144,964,000 -$16,704,000 -10% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $146,111,000 -$19,162,000 -12% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $151,881,000 -$18,770,000 -11% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $157,616,000 -$16,385,000 -9.4% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q3 2023 $161,668,000 -$17,079,000 -9.6% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $165,273,000 -$18,430,000 -10% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $170,651,000 -$17,956,000 -9.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $174,001,000 -$15,442,000 -8.2% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $178,747,000 -$17,689,000 -9% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $183,703,000 -$17,255,000 -8.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $188,607,000 -$17,064,000 -8.3% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $189,443,000 +$152,100,000 +407% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $196,436,000 +$160,333,000 +444% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $200,958,000 +$162,455,000 +422% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $205,671,000 +$175,539,000 +583% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $37,343,000 +$8,203,000 +28% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $36,103,000 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $38,503,000 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $30,132,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $29,140,000 +$14,640,000 +101% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $14,500,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.